Despite a renewed push by health officials to promote HPV vaccination, a new poll finds that only a minority of parents believe laws requiring the vaccines “…

HHS Secretary Sylvia Burwell has signed off on an $81 million fund allocation for federal agencies to continue research, though officials are stressing the…

Following the June decision by a CDC committee to recommend against any use of AstraZeneca’s FluMist Quadrivalent for the upcoming flu season, a Canadian study…

Dynavax Technologies has a new FDA Adcomm date for consideration of its hepatitis B vaccine, Heplisav-B, after the agency earlier this year pushed back its…

Scientists have been developing vaccines that could stop disease outbreaks more quickly. Now, researchers at the Massachusetts Institute of Technology are…

Vaxart has been keeping busy with R&D for its oral vaccines, and now, the company is adding another project to its list. The South San Francisco-based…

As the number of Zika cases continues to rise in the U.S., researchers at the National Institutes of Health are launching a clinical trial of a vaccine meant…

Pfizer’s Prevnar 13 sales were down in Q2 after management laid out low projections for the vaccine in 2016. But things could pick up again for Prevnar thanks…